In re Loestrin 24 Fe Antitrust Litig., No. 13-2472 (D.R.I.), Faruqi & Faruqi representing a pharmaceutical wholesaler and a proposed class of direct purchasers of Warner Chilcott’s oral contraceptive drug, Loestrin 24 Fe, alleging that Warner Chilcott and would-be generic competitors entered into a “pay for delay” conspiracy, to prevent purchasers from benefitting from lower-priced generic competition) (Faruqi & Faruqi is co-lead counsel). (settled for $120 million)
Send Information
If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.
Details
Filed on 06/19/2013
Office
1617 JFK Boulevard, Suite 1550
19103 Philadelphia, Pennsylvania
Phone (215) 277-5770
Fax (215) 277-5771
Counsel
Neill W. Clark nclark@faruqilaw.com Phone (215) 277-5770 Fax (215) 277-5771
Joseph T. Lukens jlukens@faruqilaw.com Phone (215) 277-5770 Fax (215) 277-5771
Peter Kohn pkohn@faruqilaw.com Phone (215) 277-5770 Fax (215) 277-5771